Oramed Pharmaceuticals ORMP
NASDAQ ORMP
$4.13 +0.16 (+4.03%)
At close: Nov 11, 2026 · 4:00 PM EST

Oramed Pharmaceuticals (ORMP) Gains (Losses) on Sale of Assets & Investments (2009 - 2018)

Updated

Oramed Pharmaceuticals (ORMP) posted Non Operating Investment Income of $1.03 million for FY2011.

Analysis

Oramed Pharmaceuticals (ORMP) Gains (Losses) on Sale of Assets & Investments (2009 - 2018) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gains on Sales (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn -
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn -
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -
10 Oramed Pharmaceuticals 164.02 Mn -170.72 Mn - -
Historic Data

Historic Data

Download Data
DateValue
May 31, 2018 115,000.00
Feb 28, 2018 414,000.00
Nov 30, 2017 -326,000.00
Aug 31, 2017 96,000.00
May 31, 2017 -286,000.00
Feb 28, 2017 -168,000.00
Nov 30, 2016 63,000.00
Aug 31, 2016 208,000.00
May 31, 2016 -84,000.00
Feb 29, 2016 -78,000.00
Nov 30, 2015 406,000.00
Aug 31, 2015 -395,000.00
May 31, 2015 -63,000.00
Feb 28, 2015 -7,000.00
Nov 30, 2014 359,000.00
Aug 31, 2014 -17,000.00
May 31, 2014 323,000.00
Feb 28, 2014 -490,000.00
Nov 30, 2013 -44,000.00
Aug 31, 2013 -145,908.00
API Access

Oramed Pharmaceuticals Gains (Losses) on Sale of Assets & Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-operating-investment-income&ticker=ORMP&period=max&api_key=YOUR_API_KEY